SCHEDULE 13G

Company

Whitehawk Therapeutics, Inc.

Filed

May 26, 2021

Accession Number

0000899140-21-000513

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →